End Stage Renal Disease Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global End Stage Renal Disease Market size was valued at USD 74.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 12% during the forecast period 2022 to 2028.

End-stage renal disease is associated with kidney disease and occurs during chronic kidney disease, which adversely affects kidney function. Patients with end-stage renal disease do not function properly because of problems with renal function. The kidneys help flush out waste products and excess body fluids, which are excreted from the body in the form of urine. People with end-stage renal disease who have problems excreting waste products have increased amounts of electrolytes, body fluids, and other waste products in the body.

Market Segments

By Treatment

• Transplantation
• Dialysis

By Diagnosis

• Blood tests
• Urine tests
• Imaging tests
• Kidney sample removal for testing

Key Players

• Nipro Corporation
• Baxter International, Inc.
• Medtronic Plc
• B. Braun Melsungen AG
• Asahi Kasei Medical Co., Ltd.
• Nikkiso Co., Ltd.
• JMS Co. Ltd.
• Abbott
• Amgen Inc.
• AstraZeneca
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline PLC
• Kissei Pharmaceutical Co., Ltd
• Novartis AG

Scope of the Report

The research study analyzes the global End Stage Renal Disease industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by End Stage Renal Disease Market Report

1. What was the End Stage Renal Disease Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of End Stage Renal Disease Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the End Stage Renal Disease Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.